Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by universalbabeon Dec 16, 2010 12:17pm

438 Views

Post# 17856523

RE: explain

I couldn't agree more. It is the panic selling that is driving this stock today. People could also be tax loss selling. I read the release and I think great, they will be producing soon. But people get caught up in the panic and sell. The bottom feeders will be out in full force soon. Days like today ya just gotta walk away from the computer. This company will have a producing well very soon and they have plenty more wells to drill. The upside is there. It just sucks right now.

Bullboard Posts

This battery metals stock is on a path to the global stage